Screener
Charles River Laboratories CRL DSA — Foreign exchange
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | RMS | DSA (1) | Manufacturing (2) | Total |
|---|---|---|---|---|
| December 27, 2025 | $510,844 | $1,678,518 | $574,891 | $2,764,253 |
| Acquisitions | — | 335,906 | 39,786 | 375,692 |
| Divestitures | — | (37,701) | — | (37,701) |
| Foreign exchange | (551) | (19,320) | (5,522) | (25,393) |
| June 27, 2026 | $510,293 | $1,957,403 | $609,155 | $3,076,851 |
| (1) DSA includes accumulated impairment losses of $1 billion, which were recognized in fiscal years 2008 and 2010. | ||||
| (2) Manufacturing includes accumulated impairment losses of $380 million, which were recognized in fiscal years 2024 and 2025. |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's DSA — foreign exchange?
- Charles River Laboratories (CRL) reported DSA — foreign exchange of -$4.94M in Q2 2026.
- How has Charles River Laboratories's DSA — foreign exchange changed year-over-year?
- Charles River Laboratories's DSA — foreign exchange decreased by 112.3% year-over-year, from $40.19M to -$4.94M.
- What does DSA — foreign exchange mean?
- Represents the net impact of currency fluctuations on the segment's financial results when translating foreign-denominated transactions or assets into the reporting currency. This metric highlights the sensitivity of the segment's profitability to global market volatility and international operational exposure.
Ask your AI about Charles River Laboratories's dsa — foreign exchange.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude